Observational analysis shows that vitamin D treatment lowers liver toxicity in mice with cadmium exposure, suggesting potential therapeutic benefits.
Background: Cadmium, a well-known hazardous heavy metal and non-essential component, has several negative health effects. The long-term use of cadmium toxin to develop a pulmonary model, evaluation of Irg1 gene expression and KLF-2 protein and serum IL4 levels following model induction, and evaluation of vitamin D's therapeutic effects in reducing pulmonary and hepatic complications in a mice model have not been studied.Methods: A total of 40 healthy female C57 black 6 mice weighing 20–25 g and approximately 6–8 weeks’ old were purchased from animal husbandry, Pasteur Institute of Iran. After induction of the model, the mice were assigned to the following groups such as Group 1 (G1): mice were euthanized the day after induction. Group 2(G2): mice were ethically killed 21 days after induction. Group 3(G3) mice were treated with vitamin D and euthanized 5 days after treatment. Group 4(G4): mice were treated with vitamin D and euthanized 21 days after treatment. Vitamin D3 with a concentration of 300,000 units per milliliter, which is equivalent to 7.5 mg per 1 microliter, and 13.5 μl of the main stock is equivalent to 100 ng, which is used for 1 kg of mice. Blood samples were collected to measure serum glutamic-oxaloacetic transaminase, serum glutamic-pyruvic transaminase, and alkaline phosphatase to evaluate liver toxicity.Results: Based on the results obtained, serum SGPT levels in vitamin D treatment groups did not show a significant decrease compared to cadmium groups (p >0.001). The ALP biomarker in the groups treated with vitamin D was decreased significant in comparison to untreated model groups (p<0.001). While any significant differences were not observed between the Cd model and the Cd model treated with Vitamin D.Conclusion: This study proved that administration vitamin D to some extent reduces the toxic effects of cadmium on the liver and lung.
No takes yet. Share an insight, caveat, or question.
Kardan et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: